The decision to eliminate nursing and PA degrees from ‘professional degree’ status isn’t just a financial policy choice; it’s a…
Read MoreThe decision to eliminate nursing and PA degrees from ‘professional degree’ status isn’t just a financial policy choice; it’s a…
Read MoreOmeros’s complement system drug Yartemlea is now FDA approved for treating a severe and potentially fatal complication of hematopoietic stem…
Read MoreThe solution isn’t about creating more referral pathways, but about building the measurement infrastructure that enables excellent primary care providers…
Read MoreConcierge and direct primary care models have proven their value as retention tools. Those who view these programs as measurable…
Read MoreJust as health plans have learned to identify and intervene early with chronic conditions like diabetes or heart disease, they…
Read MoreWhen tax-advantaged dollars enter a care model, they do more than expand purchasing power. They reorganize incentives, accelerate intermediary involvement,…
Read MoreA quick conversation about coverage, availability and pricing can help patients make informed decisions. The post The Future of Pharmacy…
Read MoreA new study found that continuous glucose monitors can cut healthcare costs by about 20% while also improving outcomes for…
Read MoreNew tools can predict deadly reactions to common cancer drugs, but adoption lags despite evidence. The post Genetic Screening In…
Read MoreA handful of states have issued guidance documents that illustrate how regulators are viewing the IV hydration and IV therapy…
Read More